Literature DB >> 1873033

The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein.

Y Uchida1, K Takio, K Titani, Y Ihara, M Tomonaga.   

Abstract

We have purified and characterized the growth inhibitory factor (GIF) that is abundant in the normal human brain, but greatly reduced in the Alzheimer's disease (AD) brain. GIF inhibited survival and neurite formation of cortical neurons in vitro. Purified GIF is a 68 amino acid small protein, and its amino acid sequence is 70% identical to that of human metallothionein II with a 1 amino acid insert and a unique 6 amino acid insert in the NH2-terminal and the COOH-terminal portions, respectively. The antibodies to the unique sequence of GIF revealed a distinct subset of astrocytes in the gray matter that appears to be closely associated with neuronal perikarya and dendrites. In the AD cortex, the number of GIF-positive astrocytes was drastically reduced, suggesting that GIF is down-regulated in the subset of astrocytes during AD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1873033     DOI: 10.1016/0896-6273(91)90272-2

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  124 in total

1.  CNS wound healing is severely depressed in metallothionein I- and II-deficient mice.

Authors:  M Penkowa; J Carrasco; M Giralt; T Moos; J Hidalgo
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

Review 2.  The galvanization of beta-amyloid in Alzheimer's disease.

Authors:  Ashley I Bush; Rudolph E Tanzi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 3.  Meeting of the minds: metalloneurochemistry.

Authors:  Shawn C Burdette; Stephen J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

4.  Absence of Metallothionein 3 Expression in Breast Cancer is a Rare, But Favorable Marker of Outcome that is Under Epigenetic Control.

Authors:  Seema Somji; Scott H Garrett; Xu Dong Zhou; Yun Zheng; Donald A Sens; Mary Ann Sens
Journal:  Toxicol Environ Chem       Date:  2010-10       Impact factor: 1.437

5.  Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.

Authors:  Yasmina Manso; Javier Carrasco; Gemma Comes; Gabriele Meloni; Paul A Adlard; Ashley I Bush; Milan Vašák; Juan Hidalgo
Journal:  Cell Mol Life Sci       Date:  2012-06-22       Impact factor: 9.261

6.  Membrane insertion exacerbates the α-Synuclein-Cu(II) dopamine oxidase activity: Metallothionein-3 targets and silences all α-synuclein-Cu(II) complexes.

Authors:  Jenifer S Calvo; Neha V Mulpuri; Alex Dao; Nabeeha K Qazi; Gabriele Meloni
Journal:  Free Radic Biol Med       Date:  2020-07-23       Impact factor: 7.376

7.  The crystal structure of yeast copper thionein: the solution of a long-lasting enigma.

Authors:  Vito Calderone; Benedikt Dolderer; Hans-Juergen Hartmann; Hartmut Echner; Claudio Luchinat; Cristina Del Bianco; Stefano Mangani; Ulrich Weser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-21       Impact factor: 11.205

8.  Effect of alpha-domain substitution on the structure, property and function of human neuronal growth inhibitory factor.

Authors:  Zhi-Chun Ding; Qi Zheng; Bin Cai; Wen-Hao Yu; Xin-Chen Teng; Yang Wang; Guo-Ming Zhou; Hou-Ming Wu; Hong-Zhe Sun; Ming-Jie Zhang; Zhong-Xian Huang
Journal:  J Biol Inorg Chem       Date:  2007-08-22       Impact factor: 3.358

Review 9.  Extracellular Zn2+-Dependent Amyloid-β1-42 Neurotoxicity in Alzheimer's Disease Pathogenesis.

Authors:  Yuichi Sato; Mako Takiguchi; Haruna Tamano; Atsushi Takeda
Journal:  Biol Trace Elem Res       Date:  2020-04-13       Impact factor: 3.738

10.  Influence of NH-Sgamma bonding interactions on the structure and dynamics of metallothioneins.

Authors:  Núria Romero-Isart; Baldo Oliva; Milan Vasák
Journal:  J Mol Model       Date:  2009-07-16       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.